40 results
8-K
EX-99.1
ATHA
Athira Pharma Inc
15 May 24
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
4:10pm
costs, partially offset by an increase in other indirect costs. Fosgonimeton program costs for the quarter ended March 31, 2024, were flat compared … to the quarter ended March 31, 2023, as decreases in manufacturing and contract research organization costs were offset by increases in program
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
engaging in transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of equity securities granted to them
8-K
EX-99.1
tt38imc7qn06i82y5k
9 Nov 23
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-99.1
7pce7
10 Aug 23
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-99.1
3cohkl
11 May 23
Athira Pharma Reports First Quarter 2023 Financial Results
4:11pm
DEFC14A
2esy l3h2mjk2u0
5 Apr 22
Proxy in contested solicitation
4:08pm
PREC14A
rf3b2ntqwrkou h3aka
30 Mar 22
Preliminary proxy with contested solicitation
5:23pm
DFAN14A
yijwoswmz8
30 Mar 22
Additional proxy materials by non-management
10:21am
S-8
6otoabd jhq7dw33l
28 Mar 22
Registration of securities for employees
5:13pm